Thyrostat
Thyrostat is an FDA drug label for the active ingredient FUCUS VESICULOSUS, SPONGIA TOSTA, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), ARSENICUM IODATUM, BARYTA CARBONICA, IODIUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230712.
Generic: FUCUS VESICULOSUS, SPONGIA TOSTA, HYPOPHYSIS SUIS, THYROIDINUM (SUIS), ARSENICUM IODATUM, BARYTA CARBONICA, IODIUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0488
Application:
Effective: 20230712
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 12.48% of Arsenicum Iodatum 12X, Baryta Carbonica 12X, Calcarea Carbonica 12X, Hypophysis Suis 6X, Iodium 12X, Lycopus Virginicus 12X, Natrum Muriaticum 12X, Thyroidinum (Suis) 6X; 0.10% of Fucus Vesiculosus 3X, Spongia Tosta 3X.
Indications & Usage
INDICATIONS: May temporarily relieve difficulty swallowing, flushed face, glaring eyes, excited mental state or nervousness.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.